CIBC Asset Management Inc Buys 20,684 Shares of Amrize Ltd $AMRZ

CIBC Asset Management Inc raised its position in shares of Amrize Ltd (NYSE:AMRZ) by 345.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 26,677 shares of the company’s stock after acquiring an additional 20,684 shares during the period. CIBC Asset Management Inc’s holdings in Amrize were worth $1,443,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. State of Wyoming bought a new stake in Amrize in the third quarter worth about $32,000. Basepoint Wealth LLC bought a new position in shares of Amrize during the fourth quarter valued at approximately $33,000. Laurel Wealth Advisors LLC bought a new position in shares of Amrize during the fourth quarter valued at approximately $34,000. US Bancorp DE purchased a new stake in shares of Amrize in the third quarter worth approximately $38,000. Finally, Costello Asset Management INC purchased a new stake in shares of Amrize in the third quarter worth approximately $44,000.

Insider Activity

In other news, insider Mario Gross bought 3,200 shares of the firm’s stock in a transaction that occurred on Friday, March 13th. The stock was bought at an average price of $55.29 per share, with a total value of $176,928.00. Following the completion of the transaction, the insider directly owned 30,947 shares of the company’s stock, valued at approximately $1,711,059.63. The trade was a 11.53% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Nollaig Forrest bought 2,000 shares of the stock in a transaction on Friday, May 22nd. The stock was purchased at an average price of $50.25 per share, with a total value of $100,500.00. Following the completion of the purchase, the insider owned 20,139 shares of the company’s stock, valued at $1,011,984.75. This represents a 11.03% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last 90 days, insiders have bought 64,120 shares of company stock worth $3,239,187. Insiders own 0.54% of the company’s stock.

Amrize Trading Down 5.2%

Shares of NYSE AMRZ opened at $50.78 on Tuesday. Amrize Ltd has a 1-year low of $44.12 and a 1-year high of $65.94. The business has a fifty day moving average price of $54.28 and a 200 day moving average price of $55.39. The stock has a market capitalization of $28.08 billion and a P/E ratio of 24.30. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.40 and a quick ratio of 0.89.

Amrize (NYSE:AMRZ) last announced its earnings results on Wednesday, April 29th. The company reported ($0.16) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.02). The firm had revenue of $2.18 billion during the quarter. Amrize had a return on equity of 9.84% and a net margin of 9.70%.The firm’s quarterly revenue was up 4.7% compared to the same quarter last year. Equities research analysts expect that Amrize Ltd will post 2.76 EPS for the current fiscal year.

Amrize Cuts Dividend

The company also recently disclosed a dividend, which was paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th were paid a dividend of $0.11 per share. The ex-dividend date was Tuesday, May 12th. Amrize’s payout ratio is 21.05%.

Wall Street Analysts Forecast Growth

AMRZ has been the subject of several research analyst reports. Royal Bank Of Canada decreased their target price on Amrize from $61.00 to $60.00 and set a “sector perform” rating for the company in a research report on Friday, May 1st. Citigroup reduced their price target on shares of Amrize from $76.00 to $66.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. Oppenheimer set a $68.00 price objective on shares of Amrize in a report on Friday, May 1st. JPMorgan Chase & Co. boosted their price objective on shares of Amrize from $60.00 to $70.00 and gave the company an “overweight” rating in a research report on Thursday, March 5th. Finally, Truist Financial dropped their target price on shares of Amrize from $75.00 to $65.00 and set a “buy” rating on the stock in a research note on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $64.86.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.